CancerFax
PATIENT SAFETY GUIDE

PNEUMOTHORAX AFTER LUNG RFA
WHAT IT IS, HOW COMMON, AND HOW IT IS MANAGED

Pneumothorax is the most talked-about complication of lung RFA — and the most misunderstood. It occurs frequently, but most cases are small, asymptomatic, and need no treatment. Understanding it correctly reduces unnecessary anxiety and helps patients recognise the minority of cases that do need prompt attention.

analyticsAt a Glance

  • check_circlePneumothorax occurs in 30–50% of lung RFA procedures — expected, not a complication to fear
  • check_circle70–80% of pneumothoraces are small and asymptomatic — no treatment needed
  • check_circleChest tube drainage required in only 10–20% of all lung RFA procedures
  • check_circleAll lung ablation centres have pneumothorax management protocols; serious outcomes are rare
Reviewed by: CancerFax Medical Team, Thoracic Oncology & Interventional Oncology SpecialistsLast reviewed: June 1, 20267 min read

What Is a Pneumothorax and Why Does Lung RFA Cause It?

A pneumothorax occurs when air enters the space between the lung and the chest wall — the pleural space. This air separates the lung from the chest wall, reducing the lung's ability to expand fully on inspiration.

Pneumothorax after lung ablation is not a mistake or a surgical error. It is a predictable anatomical consequence of placing a needle through the chest wall and pleural space to reach the lung. Every centre that performs lung ablation expects it and manages it routinely.
  • Why It Happens with Lung RFA

    To reach a lung tumour, the electrode needle must pass through: the skin, subcutaneous tissue, intercostal muscles, and the parietal pleura (the lining of the chest wall). This needle puncture of the pleura creates a small defect through which air can enter the pleural space from the environment or from the lung itself. As the needle is manipulated and the ablation causes local tissue changes, air leaks into the pleural space.

  • Why Lung Ablation Has a Higher Rate Than Liver or Kidney

    Liver and kidney procedures do not traverse the pleural space (for most tumour locations) — reducing pneumothorax risk to near zero. Lung procedures always cross the pleural space. Additionally, aerated lung tissue contracts easily when pneumothorax occurs, and small air collections become radiographically visible at lower volumes than in other tissues. The 30–50% incidence reflects both true pneumothorax and the high imaging sensitivity of chest CT.

Classification: Small, Moderate, and Large Pneumothorax

Not all pneumothoraces are equal. Grading severity determines management.

  • Small Pneumothorax (<20% of hemithorax)

    The majority of post-lung RFA pneumothoraces are small — a rim of air 1–2 cm wide around the lung margin on CT. Most patients are asymptomatic or have very mild shortness of breath. The management is observation and supplemental oxygen. Small pneumothoraces typically reabsorb spontaneously within 24–48 hours as the body reabsorbs the trapped air. No needle aspiration or chest tube needed.

  • Moderate Pneumothorax (20–40% of hemithorax)

    Moderate pneumothorax causes noticeable shortness of breath. The air collection is large enough that the lung has partially collapsed away from the chest wall. Management options: needle aspiration (a large-bore needle inserted to aspirate the air) or small chest tube (pigtail catheter). Most moderate pneumothoraces resolve after a single aspiration or 24–48 hours of chest tube drainage.

  • Large Pneumothorax (>40% of hemithorax) or Tension Pneumothorax

    Large pneumothorax causes significant respiratory distress — the lung is substantially collapsed. This requires urgent chest tube drainage. Tension pneumothorax — where air enters the pleural space but cannot escape, causing progressive lung compression and mediastinal shift — is a medical emergency requiring immediate needle decompression followed by chest tube. Tension pneumothorax after lung RFA is rare (<1%) but serious and requires immediate treatment.

Standard Pneumothorax Management Pathway

How post-lung RFA pneumothorax is detected and managed at experienced centres.

  1. 1

    Step 1: Immediate Post-Procedure CT

    A non-contrast CT of the chest is performed immediately after electrode removal at the end of the ablation. This identifies any pneumothorax and characterises its size. A small rim of air on immediate post-procedure CT is common and expected — does not require immediate intervention if the patient is stable.

  2. 2

    Step 2: Observation and Monitoring (4–6 Hours)

    All lung RFA patients are monitored for 4–6 hours post-procedure regardless of pneumothorax findings. Continuous pulse oximetry and respiratory rate monitoring. Supplemental oxygen (2–4 L/min) accelerates nitrogen reabsorption from a small pneumothorax. Serial clinical assessments for increasing shortness of breath, tachycardia, or falling saturations.

  3. 3

    Step 3a: Needle Aspiration (Moderate Symptomatic)

    For moderate pneumothorax with symptomatic dyspnoea: a large-bore needle (18G or 20G) is inserted into the second intercostal space, midclavicular line. Air is aspirated with a 60 mL syringe until no further air can be aspirated. Repeat chest X-ray confirms reduction in pneumothorax size. Successful aspiration avoids chest tube placement in approximately 50–60% of cases requiring intervention.

  4. 4

    Step 3b: Chest Tube Placement (Large or Persistent)

    For large pneumothorax, tension pneumothorax, failed aspiration, or persistent leak: a pigtail catheter (small flexible chest tube, 8–12 French) is inserted under local anaesthesia into the pleural space and connected to a water-seal drain or Heimlich valve. This continuously evacuates any ongoing air leak. Tube removed when air leak stops and lung is fully re-expanded on X-ray.

  5. 5

    Step 4: Discharge Decision

    No pneumothorax or small asymptomatic pneumothorax: same-day discharge with instructions for urgent return if breathlessness develops in the following 24 hours. Moderate pneumothorax resolved with aspiration: 4–8 hours additional observation before discharge. Chest tube placed: stay until tube removed (typically 24–72 hours for uncomplicated cases).

Pneumothorax Rates: Published Data from Lung Ablation Series

Incidence rates and management requirements from major published lung RFA series.

Pneumothorax Incidence and Management

Rates across multiple published series for CT-guided lung RFA. Chest tube rates apply to all procedures — not just those with pneumothorax.

  • Any Pneumothorax (Imaging-Detected)30–50%
  • Symptomatic Pneumothorax15–25%
  • Chest Tube Required10–20%
  • Tension Pneumothorax (Emergency)<1%
  • Resolve Without Intervention70–80%

Risk Factors for Pneumothorax

Some patients and tumour locations have higher pneumothorax risk — knowing these helps set realistic expectations.

  • Higher Pneumothorax Risk

    Peripheral lung tumours near the pleural surface — shorter needle track but the tumour itself may be near the pleura. Severe COPD/emphysema — bullous lung disease near the path increases leak risk substantially. Upper lobe tumours — require greater needle angulation. Prior chest surgery — adhesions between lung and chest wall may complicate needle placement. Small tumours requiring precise multi-pass electrode placement.

  • Lower Pneumothorax Risk

    Central tumours surrounded by normal lung parenchyma (though these may carry other risks like bronchial injury). Ground-glass nodules adjacent to solid lung — the solid parenchyma around the target acts as a natural tamponade. Patients with previous contralateral pneumonectomy (the remaining lung has higher surface pressure). Expert operators who minimise needle passes.

Prevention Strategies Used by Experienced Centres

While pneumothorax cannot always be prevented, experienced operators use several techniques to reduce incidence and severity.

  • Minimising the Number of Needle Passes

    Each pleural puncture adds pneumothorax risk. Operators plan the entry path carefully to reach the tumour in as few passes as possible — ideally one. CT-fluoroscopy or cone-beam CT with real-time guidance helps reach the target accurately on the first pass.

  • Autologous Blood Patch on Needle Withdrawal

    When withdrawing the electrode after ablation, some operators inject 2–5 mL of the patient's own blood (from an in-line blood trap) through the needle track as it is removed. The blood clots in the needle track and may seal the pleural puncture more quickly, reducing delayed pneumothorax. Evidence is mixed but technique is widely used.

  • Prone or Lateral Positioning

    Positioning the patient so the puncture site is at the lowest point of the pleural space reduces air accumulation at the puncture site. This is not always possible given tumour location but is used where anatomically feasible.

  • Using the Smallest Effective Electrode

    Using the smallest gauge electrode consistent with delivering adequate energy reduces the size of the pleural defect and associated pneumothorax risk.

Frequently Asked Questions

Common questions about pneumothorax after lung RFA.

About the Complication

  • I had a small pneumothorax after my lung RFA and was discharged the same day. Is that safe?

    Yes, same-day discharge with a small asymptomatic pneumothorax is standard practice at experienced lung RFA centres. Small pneumothoraces — a thin rim of air on CT — resolve spontaneously within 24–48 hours in the vast majority of patients. You should be given clear written instructions to return immediately if you develop increasing shortness of breath, chest pain, or rapid breathing in the hours to days after discharge. Contact your treating team or an emergency department urgently if these symptoms develop — they may indicate a delayed or expanding pneumothorax.

  • If I had a pneumothorax with my first lung RFA, will I have one again?

    Prior pneumothorax with lung ablation does not reliably predict future pneumothorax. Some patients have repeated procedures without pneumothorax; others develop it consistently. However, pleural adhesions may form at the site of a prior pneumothorax — which can actually reduce risk at that specific site for future procedures. If you had a small self-resolving pneumothorax, it is not a reason to avoid future lung ablation if clinically indicated.

  • How do I know if I am developing a pneumothorax at home after the procedure?

    The warning signs of a developing or expanding pneumothorax: increasing shortness of breath at rest or with minimal activity; chest pain (sharp, on the treated side); rapid heart rate; feeling faint or dizzy; reduced ability to take a deep breath. If any of these develop in the 24–72 hours after discharge, seek emergency care immediately — tell them you had a lung ablation procedure and you may be developing a pneumothorax. Carry your discharge summary with you.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Considering Lung RFA? Understand the Risks Before You Decide.

Upload your CT chest and lung function tests. Our thoracic oncology team will assess lung RFA suitability and explain the realistic pneumothorax risk for your specific tumour location and lung function.

For informational purposes only. Any breathing difficulty after a lung procedure is a medical emergency — seek immediate care. This page is educational and does not replace medical evaluation.